thus, rather than replacing hormone levels to improve vascular function in estrogen-deficient postmenopausal women and in men with low testosterone, it may be more beneficial to target the mechanisms (potentially cellular senescence) by which the reductions in these hormones drive vascular aging
Other copper peptides are less effective
The evidence is not empty, but it is narrower than many online claims suggest
Synergistic Regenerative Signaling: When combined, BPC-157, TB-500, and GHK-Cu act synergistically to stimulate angiogenesis, fibroblast activation, antioxidant protection, and inflammation resolution
This could cause a potential response bias, as more affected patients might be more prone to complete the forms